DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
批准号:
8023872
负责人:
MICHAEL T MCMAHON
金额:
$33.12万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-22 至 2014-08-31
中文摘要
描述(由申请人提供):良好的血糖控制对于减少I型糖尿病(TIDM)的终末期并发症至关重要,因此,近年来胰岛移植(ITx)受到了相当大的关注,治疗中的并发症之一涉及寻找有效的方法来预防排斥反应。胰岛的免疫隔离提供了一种减少或完全避免免疫抑制治疗的方法。在最常用的免疫隔离方法微囊化中,单个胰岛被薄藻酸盐膜包围,该膜可渗透胰岛素和代谢物,但不可渗透天然抗体。然而,这些胰岛的活力,特别是胰岛素分泌对于治疗的成功是至关重要的,并且对于监测治疗方案的改进是重要的。该提案的重点是生产微米尺寸的CEST MR可检测的藻酸盐胶囊,其含有适于治疗T1 DM的胰岛和间充质干细胞。这些胶囊将具有内置于胶囊中的CEST MR造影剂,以允许:1)检测,2)在包封的胰岛和间充质干细胞之间进行区分,以及3)远程感测环境的pH。CEST造影剂的来源将是6-24个氨基酸长的肽和嵌入藻酸盐内的CEST脂质体。我们将使用糖尿病的裸小鼠模型进行临床前研究,以允许通过萤火虫荧光素酶表达监测包封的胰岛/间充质细胞的状态。
公共卫生相关性:近年来,胰岛移植(ITx)在治疗1型糖尿病(T1 DM)方面受到了相当大的关注。该提案的重点是生产免疫保护性胰岛细胞胶囊,其适用于治疗,并允许使用可生物降解的CEST造影剂对这些胰岛的pH值进行MR监测。
英文摘要
DESCRIPTION (provided by applicant): Good glycemic control is critical in reducing the end-stage complications of Type I Diabetes Mellitus (TIDM) and, for this reason, islet transplantation (ITx) has received considerable attention in recent years, with one of the complications in the treatment involves finding an effective means to prevent rejection. Immuno-isolation of islets provides a means to reduce or avoid immunosuppressive therapy altogether. In the most commonly used method of immuno-isolation, microencapsulation, individual islets are surrounded with thin alginate membranes that are permeable to insulin and metabolites, but are impermeable to native antibodies. However, the viability and in particular the insulin secretion of these islets are critical for the success of the therapy, and would be important to monitor for refinement of the treatment protocol. This proposal is focused on the production of micron sized CEST MR detectable alginate capsules containing both islet and mesenchymal stem cells which are appropriate for the treatment of T1DM. These capsules will have CEST MR contrast agents built into the capsule to allow: 1) detection, 2) discrimination between encapsulated islet and mesynchymal stem cells and 3) remote sensing of the pH of the environment. The source of the CEST contrast will be 6-24 amino acid long peptides and CEST liposomes embedded within the alginate. We will perform pre-clinical studies using a nude based mouse model of diabetes to allow monitoring of the status of encapsulated islets/ mesenchymal cells through firefly luciferase expression.
PUBLIC HEALTH RELEVANCE: Islet transplantation (ITx) has received considerable attention in recent years for treatment of Type 1 Diabetes Melitus (T1DM). This proposal is focused on the production of immunoprotective islet cell capsules which are appropriate for treatment and allow MR monitoring of the pH these islets using biodegradable CEST contrast agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema
-
批准号:10551303
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2020
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema
-
批准号:10337274
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2020
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:10226212
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2017
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8479358
-
项目类别:
-
资助金额:$57.81万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8292578
-
项目类别:
-
资助金额:$61.89万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8677891
-
项目类别:
-
资助金额:$56.52万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
-
批准号:8305994
-
项目类别:
-
资助金额:$60.96万
-
财政年份:2011
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8323997
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8525116
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
-
批准号:8146032
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2010
-
负责人:MICHAEL T MCMAHON
-
依托单位:
16.4T Vertical Wide Bore Animal MR Imager
-
批准号:7498705
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2009
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7448639
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7130476
-
项目类别:
-
资助金额:$11.59万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7265096
-
项目类别:
-
资助金额:$11.81万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7667850
-
项目类别:
-
资助金额:$12.82万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
-
批准号:7912901
-
项目类别:
-
资助金额:$13.2万
-
财政年份:2006
-
负责人:MICHAEL T MCMAHON
-
依托单位:
A SOLID STATE NMR INVESTIGATION OF BACTERIORHODOPSIN
-
批准号:6518893
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2001
-
负责人:MICHAEL T MCMAHON
-
依托单位:
A SOLID STATE NMR INVESTIGATION OF BACTERIORHODOPSIN
-
批准号:6294279
-
项目类别:
-
资助金额:$3.48万
-
财政年份:2001
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:9984374
-
项目类别:
-
资助金额:$31.04万
-
财政年份:--
-
负责人:MICHAEL T MCMAHON
-
依托单位:
CEST MRI Agents for Receptor Imaging
-
批准号:9358163
-
项目类别:
-
资助金额:$27.62万
-
财政年份:--
-
负责人:MICHAEL T MCMAHON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ISLET1调控小鼠牙釉质再生的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:张斌
-
依托单位:
转录因子Islet-1 在糖尿病视网膜微血管病变形成中调控作用的研究
-
批准号:2019JJ40507
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:熊思齐
-
依托单位:
采用CRISPR/Cas9技术探讨转录因子Islet-1调控VEGFA的表达在糖尿病视网膜病变中作用的研究
-
批准号:81974137
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:熊思齐
-
依托单位:
Islet-1诱导MSCs特化心肌细胞的电生理构建与能量代谢重塑调控
-
批准号:81970244
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:朱静
-
依托单位:
Islet-1修饰MSCs来源外泌体通过mTOR通路修复受损心肌细胞的机制研究
-
批准号:81700250
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:许皓
-
依托单位:
Islet-1与Akt竞争破解MSCs干性促其心肌细胞特化机制研究
-
批准号:81670270
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2016
-
负责人:朱静
-
依托单位:
Islet-1调控的磷酸戊糖途径异常在弥漫大B细胞淋巴瘤中的作用及分子机制
-
批准号:81560037
-
项目类别:地区科学基金项目
-
资助金额:40.0万元
-
批准年份:2015
-
负责人:张巧
-
依托单位:
转录因子Islet1 在心脏起搏细胞的发育和功能中的调控机制
-
批准号:81370196
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:梁兴群
-
依托单位:
转录因子Islet-1在视网膜新生血管形成中调控作用的研究
-
批准号:81000388
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:熊思齐
-
依托单位:
胰岛因子1(Islet-1)促进肿瘤细胞增殖的分子机制研究
-
批准号:81071675
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:王卫平
-
依托单位: